1. Epigenetics
    TGF-beta/Smad
  2. PKC
  3. CC-90005

CC-90005 

Cat. No.: HY-132304
Handling Instructions

CC-90005 is a potent, selective and orally active inhibitor of protein kinase C-θ (PKC-θ), with an IC50 of 8 nM. CC-90005 shows selectivity for PKC-θ over PKC-δ (IC50=4440 nM). CC-90005 can inhibit T cell activation by IL-2 expression.

For research use only. We do not sell to patients.

CC-90005 Chemical Structure

CC-90005 Chemical Structure

CAS No. : 1799574-70-1

Size Price Stock
5 mg USD 580 Ask For Quote & Lead Time
10 mg USD 980 Ask For Quote & Lead Time
25 mg USD 1900 Ask For Quote & Lead Time
50 mg USD 3200 Ask For Quote & Lead Time
100 mg USD 5000 Ask For Quote & Lead Time

* Please select Quantity before adding items.

Top Publications Citing Use of Products
  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

CC-90005 is a potent, selective and orally active inhibitor of protein kinase C-θ (PKC-θ), with an IC50 of 8 nM. CC-90005 shows selectivity for PKC-θ over PKC-δ (IC50=4440 nM). CC-90005 can inhibit T cell activation by IL-2 expression[1].

IC50 & Target[1]

PKCθ

8 nM (IC50)

In Vitro

CC-90005 shows the exquisite selectivity of CC-90005, with IC50s for all other family members of >3 μM[1].
CC-90005 is a moderate inhibitor of both CYP2C9 (IC50=8 μM) and CYP2C19 (IC50=5.9 μM) in human liver microsomes[1].
CC-90005 inhibits IL-2 expression in LRS_WBC human PBMCs, with an IC50 of 0.15 μM[1].
CC-90005 (1-10 μM; 24 h) inhibits T cell proliferation in PBMCs by 51% at 1 μM and 88% at 3 μM[1].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

In Vivo

CC-90005 (3-30 mg/kg; p.o. twice daily for 4 days) significantly reduces the popliteal lymph node (PLN) size in a model of chronic T cell activation[1].
CC-90005 (100 mg/kg; a single p.o.) significantly inhibits plasma and spleen IL-2 release by 51 and 54%, respectively[1].
CC-90005 exhibits reasonable oral bioavailability (66 and 46%) and Cmax (1.18 and 1.2 μM) following oral administration (10 and 3 mg/kg) in rat and dog, respectively[1].
CC-90005 exhibits the mean residence time (0.52 and 2.0 h), CL (69.1 and 20.5 mL/min/kg) and Vss (2.11 and 2.44 L/kg) following intravenous administration (2 and 1 mg/kg) in rat and dog, respectively[1].

MCE has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: B6D2F1 mice (20 g) were injected with allogeneic spleen cells
Dosage: 3, 10, 30 mg/kg
Administration: P.o. twice daily for 4 days
Result: Inhibited PLN size by 45 and 38% at doses of 10 and 30 mg/kg, respectively.
Clinical Trial
Molecular Weight

447.48

Formula

C₂₁H₂₇F₂N₇O₂

CAS No.
Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Salutation

Applicant Name *

 

Email address *

Phone number *

 

Organization name *

Department *

 

Requested quantity *

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
CC-90005
Cat. No.:
HY-132304
Quantity:
MCE Japan Authorized Agent: